Argentina vs Guatemala: The number of people with susceptibility test result for rifampicin
Argentina
2,309
in 2021
Guatemala
2,022
in 2021
Argentina rank
44th
Guatemala rank
46th
The number of people with susceptibility test result for rifampicin over time
- Argentina
- Guatemala
How they compare
Argentina currently reports 2,309 against 2,022 in Guatemala, a difference of 287.
That makes Argentina's figure about 1.1 times Guatemala's.
The two have swapped places 2 times across 5 shared years of data; in 2017 it was Argentina ahead.
Argentina ranks 44th and Guatemala ranks 46th of 155 countries.
Argentina has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Argentina | Guatemala | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1,204 | 1,126 | 78.33 | Argentina |
| 2020s | 1,732 | 1,352 | 380 | Argentina |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Argentina or Guatemala?
- Argentina, at 2,309 against 2,022 in Guatemala as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Argentina and Guatemala?
- 287, with Argentina ahead.
- How many years of comparable data are there for Argentina and Guatemala?
- 5 years are reported by both, from 2017 to 2021.
- How do Argentina and Guatemala rank globally for the number of people with susceptibility test result for rifampicin?
- Argentina ranks 44th and Guatemala ranks 46th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.